Early outcomes of lung resections in non-small cell lung cancer after COVID-19 pneumonia

Objective: There is limited literature on patients with a history of COVID-19 pneumonia who underwent anatomical lung resection for non-small cell lung cancer (NSCLC). This study was aimed to share the early postoperative outcomes in patients who underwent lung resection after COVID-19 pneumonia. Ma...

Full description

Bibliographic Details
Main Authors: Baris Hekimoglu, Muhammet Ali Beyoglu
Format: Article
Language:English
Published: Elsevier 2022-08-01
Series:Asian Journal of Surgery
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1015958422004717
_version_ 1818242140574056448
author Baris Hekimoglu
Muhammet Ali Beyoglu
author_facet Baris Hekimoglu
Muhammet Ali Beyoglu
author_sort Baris Hekimoglu
collection DOAJ
description Objective: There is limited literature on patients with a history of COVID-19 pneumonia who underwent anatomical lung resection for non-small cell lung cancer (NSCLC). This study was aimed to share the early postoperative outcomes in patients who underwent lung resection after COVID-19 pneumonia. Materials and methods: We retrospectively evaluated 30 patients who underwent lobectomy with thoracotomy and systematic mediastinal lymph node dissection due to NSCLC in a single center between November 2018 and September 2021. The patients were divided into two groups regarding COVID-19 pneumonia history; the COVID-19 group consisted of 14 patients (46.7%) and the non-COVID-19 group 16 (53.3%) patients. The patients’ age, gender, comorbidity, Charlson Comorbidity Index (CCI) score, forced expiratory volume in 1 s (FEV1) value, tumor type and size, resection type, postoperative air leak duration, total drainage volume, drain removal time, postoperative complications, and length of stay (LOS) were recorded. Results: 9 (30%) patients were female, and 21 (70%) were male. The mean age was 62.1 ± 8.91 years. Our comparison of postoperative air leak duration, total drainage volume, time to drain removal, postoperative complications, and LOS between the COVID-19 and non-COVID-19 groups revealed no statistically significant difference. Conclusion: Anatomical lung resection can be performed safely in NSCLC patients with a history of COVID-19 pneumonia without significant difference in early postoperative morbidity and mortality.
first_indexed 2024-12-12T13:40:30Z
format Article
id doaj.art-9cd035f4059848bdb63eeeadb7d117c7
institution Directory Open Access Journal
issn 1015-9584
language English
last_indexed 2024-12-12T13:40:30Z
publishDate 2022-08-01
publisher Elsevier
record_format Article
series Asian Journal of Surgery
spelling doaj.art-9cd035f4059848bdb63eeeadb7d117c72022-12-22T00:22:49ZengElsevierAsian Journal of Surgery1015-95842022-08-0145815531558Early outcomes of lung resections in non-small cell lung cancer after COVID-19 pneumoniaBaris Hekimoglu0Muhammet Ali Beyoglu1Department of Thoracic Surgery, Faculty of Medicine, University of Ordu, Ordu, Turkey; Corresponding author.Department of General Thoracic Surgery and Lung Transplantation, Ankara City Hospital, University of Health Sciences, Ankara, TurkeyObjective: There is limited literature on patients with a history of COVID-19 pneumonia who underwent anatomical lung resection for non-small cell lung cancer (NSCLC). This study was aimed to share the early postoperative outcomes in patients who underwent lung resection after COVID-19 pneumonia. Materials and methods: We retrospectively evaluated 30 patients who underwent lobectomy with thoracotomy and systematic mediastinal lymph node dissection due to NSCLC in a single center between November 2018 and September 2021. The patients were divided into two groups regarding COVID-19 pneumonia history; the COVID-19 group consisted of 14 patients (46.7%) and the non-COVID-19 group 16 (53.3%) patients. The patients’ age, gender, comorbidity, Charlson Comorbidity Index (CCI) score, forced expiratory volume in 1 s (FEV1) value, tumor type and size, resection type, postoperative air leak duration, total drainage volume, drain removal time, postoperative complications, and length of stay (LOS) were recorded. Results: 9 (30%) patients were female, and 21 (70%) were male. The mean age was 62.1 ± 8.91 years. Our comparison of postoperative air leak duration, total drainage volume, time to drain removal, postoperative complications, and LOS between the COVID-19 and non-COVID-19 groups revealed no statistically significant difference. Conclusion: Anatomical lung resection can be performed safely in NSCLC patients with a history of COVID-19 pneumonia without significant difference in early postoperative morbidity and mortality.http://www.sciencedirect.com/science/article/pii/S1015958422004717COVID-19Lung cancerThoracic surgeryLobectomy
spellingShingle Baris Hekimoglu
Muhammet Ali Beyoglu
Early outcomes of lung resections in non-small cell lung cancer after COVID-19 pneumonia
Asian Journal of Surgery
COVID-19
Lung cancer
Thoracic surgery
Lobectomy
title Early outcomes of lung resections in non-small cell lung cancer after COVID-19 pneumonia
title_full Early outcomes of lung resections in non-small cell lung cancer after COVID-19 pneumonia
title_fullStr Early outcomes of lung resections in non-small cell lung cancer after COVID-19 pneumonia
title_full_unstemmed Early outcomes of lung resections in non-small cell lung cancer after COVID-19 pneumonia
title_short Early outcomes of lung resections in non-small cell lung cancer after COVID-19 pneumonia
title_sort early outcomes of lung resections in non small cell lung cancer after covid 19 pneumonia
topic COVID-19
Lung cancer
Thoracic surgery
Lobectomy
url http://www.sciencedirect.com/science/article/pii/S1015958422004717
work_keys_str_mv AT barishekimoglu earlyoutcomesoflungresectionsinnonsmallcelllungcanceraftercovid19pneumonia
AT muhammetalibeyoglu earlyoutcomesoflungresectionsinnonsmallcelllungcanceraftercovid19pneumonia